The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

Epstein, 2005, . ISUP Grading Committee. The 2005 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma., Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1

Esserman, 2014, . Addressing overdiagnosis and overtreatment in cancer: a prescription for change., Lancet Oncol, 15, e234, 10.1016/S1470-2045(13)70598-9

Bailar, 1966, 3rd, Mellinger GT, Gleason DF. Survival rates of patients with prostatic cancer, tumor stage, and differentiationpreliminary report., Cancer Chemother Rep, 50, 129

Gleason, 1966, Classification of prostatic carcinomas., Cancer Chemother Rep, 50, 125

Mellinger, 1967, The histology and prognosis of prostatic cancer., J Urol, 97, 331, 10.1016/S0022-5347(17)63039-8

Gleason, 1974, Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging., J Urol, 111, 58, 10.1016/S0022-5347(17)59889-4

Mellinger, 1977, Prognosis of prostatic carcinoma., Recent Results Cancer Res, 60, 61, 10.1007/978-3-642-81095-4_6

McNeal, 1996, Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations., Am J Surg Pathol, 20, 802, 10.1097/00000478-199607000-00003

Latour, 2008, . Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology., Am J Surg Pathol, 32, 1532, 10.1097/PAS.0b013e318169e8fd

Iczkowski, 2011, . Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome., Am J Clin Pathol, 136, 98, 10.1309/AJCPZ7WBU9YXSJPE

Kir, 2014, . The association of the cribriform pattern with outcome for prostatic adenocarcinomas., Pathol Res Pract, 210, 640, 10.1016/j.prp.2014.06.002

Sarbay, 2014, . Significance of the cribriform pattern in prostatic adenocarcinomas., Pathol Res Pract, 210, 554, 10.1016/j.prp.2014.03.003

Trudel, 2014, . Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort., Eur J Cancer, 50, 1610, 10.1016/j.ejca.2014.03.009

Kweldam, 2015, . Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in gleason score 7 prostate cancer., Mod Pathol, 28, 457, 10.1038/modpathol.2014.116

Lotan, 2009, Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy., Hum Pathol, 40, 471, 10.1016/j.humpath.2008.10.002

Lane, 2006, . Mucinous adenocarcinoma of the prostate does not confer poor prognosis., Urology, 68, 825, 10.1016/j.urology.2006.04.028

Osunkoya, 2008, Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases., Am J Surg Pathol, 32, 468, 10.1097/PAS.0b013e3181589f72

Kovi, 1985, Ductal spread in prostatic carcinoma., Cancer, 56, 1566, 10.1002/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y

Guo, 2006, Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance., Mod Pathol, 19, 1528, 10.1038/modpathol.3800702

Robinson, 2010, Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings., J Urol, 184, 1328, 10.1016/j.juro.2010.06.017

Zhao, 2015, Yao J, et al.., Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer Prostate, 75, 225

Watts, 2013, . Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study., Histopathology, 63, 574, 10.1111/his.12198

Van der Kwast, 2012, . Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy., Eur J Cancer, 48, 1318, 10.1016/j.ejca.2012.02.003

Kryvenko, 2013, . Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens., Arch Pathol Lab Med, 137, 610, 10.5858/arpa.2012-0128-OA

Kimura, 2014, . Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens., Prostate, 74, 680, 10.1002/pros.22786

Miyai, 2014, . Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between precursor-like and regular type lesions., Int J Clin Exp Pathol, 7, 2518

Ghani, 2005, . Trends in reporting Gleason score 1991 to 2001: changes in the pathologists practice., Eur Urol, 47, 196, 10.1016/j.eururo.2004.07.029

Fine, 2008, A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score., J Urol, 179, 1335, 10.1016/j.juro.2007.11.057

Steinberg, 1997, . Correlation of prostate needle biopsy and radical prostatectomy gleason grade in academic and community settings., Am J Surg Pathol, 21, 566, 10.1097/00000478-199705000-00010

Helpap, 2006, The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens., Virchows Arch, 449, 622, 10.1007/s00428-006-0310-6

Resnick, 2013, . Long-term functional outcomes after treatment for localized prostate cancer., N Engl J Med, 368, 436, 10.1056/NEJMoa1209978

Wilt, 2012, . Radical prostatectomy versus observation for localized prostate cancer., N Engl J Med, 367, 203, 10.1056/NEJMoa1113162

Bill-Axelson, 2014, . Radical prostatectomy or watchful waiting in early prostate cancer., N Engl J Med, 370, 932, 10.1056/NEJMoa1311593

DAmico, 1998, . Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer., JAMA, 280, 969, 10.1001/jama.280.11.969

Chan, 2000, . Prognostic significance of Gleason score 34 versus gleason score 43 tumor at radical prostatectomy., Urology, 56, 823, 10.1016/S0090-4295(00)00753-6

Gonzalgo, 2006, . Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate., Urology, 67, 115, 10.1016/j.urology.2005.07.037

Grober, 2004, . Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors., Can J Urol, 11, 2157

Kang, 2007, . Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database., Urology, 70, 277, 10.1016/j.urology.2007.03.059

Lau, 2001, . Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4., J Urol, 166, 1692, 10.1016/S0022-5347(05)65655-8

Merrick, 2002, . Biochemical outcome for hormone-naive patients with Gleason score 34 versus 43 prostate cancer undergoing permanent prostate brachytherapy., Urology, 60, 98, 10.1016/S0090-4295(02)01640-0

Sakr, 2000, . Gleason score 7 prostate cancer: a heterogeneous entity Correlation with pathologic parameters and disease-free survival., Urology, 56, 730, 10.1016/S0090-4295(00)00791-3

Wright, 2009, . Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 43 and Gleason 34 tumors in a population based cohort., J Urol, 182, 2702, 10.1016/j.juro.2009.08.026

Zumsteg, 2013, . A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy., Eur Urol, 64, 895, 10.1016/j.eururo.2013.03.033

Spratt, 2013, . Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis., Int J Radiat Oncol Biol Phys, 85, 1254, 10.1016/j.ijrobp.2012.10.013

Sabolch, 2011, . Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation., Int J Radiat Oncol Biol Phys, 81, e351, 10.1016/j.ijrobp.2011.01.063

Stenmark, 2011, . Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease., Int J Radiat Oncol Biol Phys, 81, e335, 10.1016/j.ijrobp.2011.04.037

Stock, 2006, Disease-specific survival following the brachytherapy management of prostate cancer., Int J Radiat Oncol Biol Phys, 64, 810, 10.1016/j.ijrobp.2005.09.005

Sylvester, 2011, . Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience., Int J Radiat Oncol Biol Phys, 81, 376, 10.1016/j.ijrobp.2010.05.042

Stone, 2011, . Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy., J Urol, 185, 495, 10.1016/j.juro.2010.09.099

Berman, 2014, When is prostate cancer really cancer Urol Clin North Am., , 41, 339

Pierorazio, 2013, . Prognostic Gleason grade grouping: data based on the modified Gleason scoring system., BJU Int, 111, 753, 10.1111/j.1464-410X.2012.11611.x

Epstein, 2012, . Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades., Eur Urol, 61, 1019, 10.1016/j.eururo.2012.01.050